Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid.

Crespillo AJ, Praena B, Bello-Morales R, Lerma L, Vázquez-Calvo A, Martín-Acebes MA, Tabarés E, Sobrino F, López-Guerrero JA.

Virus Res. 2016 Mar 2;214:71-9. doi: 10.1016/j.virusres.2016.01.009. Epub 2016 Jan 21.

PMID:
26805038
2.

Inhibition of enveloped virus infection of cultured cells by valproic acid.

Vázquez-Calvo A, Saiz JC, Sobrino F, Martín-Acebes MA.

J Virol. 2011 Feb;85(3):1267-74. doi: 10.1128/JVI.01717-10. Epub 2010 Nov 24.

3.

The effect of cellular differentiation on HSV-1 infection of oligodendrocytic cells.

Bello-Morales R, Crespillo AJ, García B, Dorado LÁ, Martín B, Tabarés E, Krummenacher C, de Castro F, López-Guerrero JA.

PLoS One. 2014 Feb 13;9(2):e89141. doi: 10.1371/journal.pone.0089141. eCollection 2014.

4.

Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.

Simon G, Moog C, Obert G.

Chem Biol Interact. 1994 Jun;91(2-3):111-21.

PMID:
7514959
5.

Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels.

Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G.

J Gen Virol. 1996 Sep;77 ( Pt 9):1993-9.

PMID:
8810995
6.

Houttuynia cordata targets the beginning stage of herpes simplex virus infection.

Hung PY, Ho BC, Lee SY, Chang SY, Kao CL, Lee SS, Lee CN.

PLoS One. 2015 Feb 2;10(2):e0115475. doi: 10.1371/journal.pone.0115475. eCollection 2015.

7.

Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.

Vázquez-Calvo Á, Martín-Acebes MA, Sáiz JC, Ngo N, Sobrino F, de la Torre JC.

Antiviral Res. 2013 Aug;99(2):172-9. doi: 10.1016/j.antiviral.2013.05.012. Epub 2013 Jun 2.

8.

Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.

Iwata S, Saito T, Ito Y, Kamakura M, Gotoh K, Kawada J, Nishiyama Y, Kimura H.

Cancer Sci. 2012 Feb;103(2):375-81. doi: 10.1111/j.1349-7006.2011.02127.x. Epub 2011 Nov 22.

10.

The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.

Alvarez-Breckenridge CA, Yu J, Price R, Wei M, Wang Y, Nowicki MO, Ha YP, Bergin S, Hwang C, Fernandez SA, Kaur B, Caligiuri MA, Chiocca EA.

J Virol. 2012 Apr;86(8):4566-77. doi: 10.1128/JVI.05545-11. Epub 2012 Feb 8.

11.

Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid.

Michaelis M, Köhler N, Reinisch A, Eikel D, Gravemann U, Doerr HW, Nau H, Cinatl J Jr.

Biochem Pharmacol. 2004 Aug 1;68(3):531-8.

PMID:
15242819
12.

Role of Proteolipid Protein in HSV-1 Entry in Oligodendrocytic Cells.

Bello-Morales R, Crespillo AJ, Praena B, Tabarés E, Revilla Y, García E, Fraile-Ramos A, Baron W, Krummenacher C, López-Guerrero JA.

PLoS One. 2016 Jan 25;11(1):e0147885. doi: 10.1371/journal.pone.0147885. eCollection 2016.

13.

Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.

Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gümbel H, Doerr HW, Nau H, Cinatl J Jr.

Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3451-7.

PMID:
16123451
14.

Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro.

Witvrouw M, Schmit JC, Van Remoortel B, Daelemans D, Esté JA, Vandamme AM, Desmyter J, De Clercq E.

AIDS Res Hum Retroviruses. 1997 Jan 20;13(2):187-92.

PMID:
9007204
15.

Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Gorres KL, Daigle D, Mohanram S, Miller G.

J Virol. 2014 Jul;88(14):8028-44. doi: 10.1128/JVI.00722-14. Epub 2014 May 7.

16.

Effect of black tea extract on herpes simplex virus-1 infection of cultured cells.

Cantatore A, Randall SD, Traum D, Adams SD.

BMC Complement Altern Med. 2013 Jun 18;13:139. doi: 10.1186/1472-6882-13-139.

17.

Trichosanthin affects HSV-1 replication in Hep-2 cells.

He DX, Tam SC.

Biochem Biophys Res Commun. 2010 Nov 26;402(4):670-5. doi: 10.1016/j.bbrc.2010.10.080. Epub 2010 Oct 29.

PMID:
20971060
18.

Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication.

Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Fujii N.

Virology. 2005 Jul 20;338(1):173-81.

19.

Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.

Zheng K, Chen M, Xiang Y, Ma K, Jin F, Wang X, Wang X, Wang S, Wang Y.

Biochem Biophys Res Commun. 2014 Apr 18;446(4):990-6. doi: 10.1016/j.bbrc.2014.03.050. Epub 2014 Mar 19.

PMID:
24657267
20.

Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.

Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ.

Antiviral Res. 2006 Dec;72(3):242-51. Epub 2006 Jul 14.

PMID:
16876885

Supplemental Content

Support Center